Objective: Mitochondrial permeability transition pore opening plays a critical role in mediating the mitochondrial response to ischemia/reperfusion injury and initiation of apoptosis. We tested whether inhibition of mitochondrial permeability transition pore opening with cyclosporine A prevented apoptosis-related alterations in mitochondrial structure and function after cardioplegic arrest.
T he early postoperative period after neonatal cardiac surgery is notable for myocardial dysfunction. 1, 2 Recent data indicate that apoptosis is induced after cardioplegic arrest, suggesting a potential role for apoptosis in postoperative myocardial dysfunction. 3, 4 As a critical mediator in apoptosis signaling pathways, mitochondria integrate upstream death stimuli and undergo structural and functional remodeling with subsequent transmission of signals to downstream executioner proteins. 5 We previously identified Bax translocation to the mitochon-dria, mitochondrial permeabilization, cytochrome c release, and deficits in mitochondrial Complex I function within 6 hours after cardioplegic arrest and reperfusion. 6, 7 Because these events occur in a time frame similar to that of postoperative cardiac dysfunction, we hypothesized that apoptosis-related mitochondrial dysfunction may contribute to postoperative myocardial dysfunction. 6 The mitochondrial permeability transition pore (MPTP) is a nonspecific pore that has been implicated as a potential mediator of myocardial ischemic injury and initiation of apoptosis. 8, 9 Pharmacologic inhibition of MPTP opening is associated with myocardial protection against ischemic/ reperfusion injury. 10, 11 Cyclosporine A (CsA), which acts by inhibiting the peptidyl-prolyl cis-trans isomerase activity of CyP-D, is a specific inhibitor of MPTP opening, and the protective effects of CsA after ischemic injury have been reported in a variety of in vitro 12, 13 and in vivo 14 animal models of unprotected and protected 15 ischemia. The potential for CsA-mediated MPTP inhibition to mitigate mitochondrial injury after cardioplegic arrest has rarely been explored in a large animal in vivo model. Therefore, the current study was designed to examine the effect of CsA on mitochondrial injury and apoptosis signaling in a clinically relevant model of neonatal cardioplegic arrest.
Materials and Methods

Surgical Preparation
Newborn piglets (ϳ14 days) were anesthetized with intravenous (IV) sodium pentothal, intubated, and maintained with 1% isoflurane. Cardiopulmonary bypass (CPB) was initiated with a blood prime and passive cooling to 28°C to 30°C core temperature. The aorta was crossclamped, and cold antegrade crystalloid cardioplegia (Plegisol; Hospira, Inc, Lake Forest, Ill) (4°C, 50-70 mm Hg perfusion pressure; 20 mL/kg followed by 15 mL/kg every 20 minutes) was administered. Topical cooling and aorta and pulmonary artery venting were used. After 60 minutes, the crossclamp was removed and the animal was rewarmed; after 10 to 20 minutes, CPB was terminated. General anesthesia was maintained for 6 hours. Arterial blood gases, electrolytes, and hematocrit were maintained in a physiologic range. Inotropic agents were not administered.
After 6 hours, the heart was quickly excised and perfused with ice-cold phosphate-buffered saline. Left ventricular myocardium was excised, snap-frozen in liquid nitrogen, and stored (Ϫ80°C). For mitochondrial oxygen consumption and cytochrome c release measurements, myocardium was immediately fractionated as described. 6 Fresh mitochondrial fractions were used for oxygen consumption measurements, mitochondrial calcium tolerance experiments, and electron microcopy. Myocardium was embedded in optimal cutting temperature (OCT) compound, frozen in liquid nitrogen, and stored at Ϫ80°C for apoptotic index assessment and fluorescent immunohistochemistry. Mitochondrial purity was confirmed by inspection of randomly chosen electron micrographs and by porin concentrations and citrate synthase activity.
Comparison was made among the following groups: cold crystalloid cardioplegia (CCP, n ϭ 5); CCP with IV administration of CsA (10 mg/kg Ϫ1 ; Novartis Pharmaceuticals Canada Inc, Dorval, Quebec) 14 immediately before initiation of CPB (CCP ϩ CsA, n ϭ 5); and non-CPB controls (n ϭ 5). For the non-CPB protocol, after anesthesia for 6 hours, a thoracotomy was performed and myocardial tissue was harvested as described above.
All animals received humane care in compliance with the "Guide for the Care and Use of Laboratory Animals" prepared by the Association for Assessment and Accreditation of Laboratory Animal Care (March 1999), and approval was obtained from the Animal Resource Committee at the Hospital for Sick Children.
Electron Microscopy
The mitochondrial fraction was resuspended and fixed with 2% glutaraldehyde overnight. Mitochondria were postfixed, dehydrated, and embedded in Epon. Ultrathin sections were stained with lead citrate and uranyl acetate, and examined with a Hitachi H 7000 (Hitachi High-Technologies Corp, Schaumburg, Ill) transmission electron microscope at a magnification of 10,000ϫ.
Mitochondrial Fractionation for Biochemical Analysis
Mitochondrial fractionation was performed as described. 6 Myocardium samples were mechanically homogenized and lysed. Unlysed cells and nuclei were removed by centrifugation at 750g (5 minutes ϫ 2 at 4°C). The supernatant was spun at 8000g (25 minutes at 4°C), and the resulting mitochondrial pellets were resuspended and frozen (Ϫ80°C).
Mitochondrial Bax Translocation
Translocation of Bax from cytosol to mitochondria was examined by Western blot of mitochondrial protein fractions. Membranes were probed with anti-rabbit Bax (N-20, 1:1000; Santa Cruz Biotechnology, Inc, Santa Cruz, Calif). For protein loading control, the membranes were stripped and reprobed with anti-mouse mitochondrial porin (1:20,000; Molecular Probes, Inc, Carlsbad, Calif). Secondary antibodies were coupled to horseradish peroxidase (antirabbit immunoglobulin [Ig]G 1:1000; anti-mouse IgG 1:10,000, Santa Cruz Biotechnology, Inc).
Cytochrome c Release
Mitochondrial outer membrane permeability was evaluated by measurement of cytochrome c release into the cytosol. After subcellular fractionation, cardiac cytosolic samples were standardized for protein concentration by a protein assay kit (Bio-Rad, Her-
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CCP ϭ cold crystalloid cardioplegia COX IV ϭ cytochrome c oxidase IV CPB ϭ cardiopulmonary bypass CsA ϭ cyclosporine A Ig ϭ immunoglobulin IV ϭ intravenous MPTP ϭ mitochondrial permeability transition pore OCT ϭ optimal cutting temperature TUNEL ϭ deoxyuride-5=-triphosphate biotin nick end labeling cules, Calif), denatured, and subsequently transferred to nitrocellulose membranes. The membrane was blocked with 5% nonfat milk and incubated overnight at 4°C with specific anti-mouse cytochrome c (1:2000; BD Biosciences Pharmingen, San Diego, Calif). For protein loading control, membranes were stripped and reprobed with anti-goat ␤-actin (1:5,000; Santa Cruz Biotechnology, Inc). Secondary antibodies were coupled to horseradish peroxidase (anti-mouse IgG 1:5,000; anti-goat IgG 1:10,000 Santa Cruz Biotechnology, Inc). Cytosolic cytochrome c was normalized to ␤-actin and cytosolic citrate synthase activity. 
Deoxyuride-5=-Triphosphate Biotin Nick End Labeling Staining
OCT-embedded transverse ventricular slices were cut into 10-m serial sections that were used for deoxyuride-5=-triphosphate biotin nick end labeling (TUNEL). TUNEL was performed with the In Situ Cell Death Detection Kit (Roche Diagnostics, Indianapolis, Ind) according to the manufacturer's instructions. After TUNEL, all nuclei were counterstained with DAPI. The number of TUNELpositive myocytes and the number of total myocytes were counted in 25 random high-power fields (ϫ600) by a Leica (Deerfield, Ill) fluorescent microscope with OpenLab software (Improvision). Approximately 5000 myocytes were examined at least 3 different sections from each animal.
Mitochondrial Calcium Tolerance: MPTP Opening Threshold Experiments
Mitochondrial calcium tolerance experiments were determined by Ca 2ϩ -induced swelling of isolated cardiac mitochondria. 18 Administration of exogenous calcium results in mitochondrial swelling, which is measured spectrophotometrically as a reduction in absorbance at 520 nm (A 520 ). Isolated cardiac mitochondria were resuspended in a swelling buffer to a final protein concentration of 0.22 mg/mL. Two picomoles of CaCl 2 were added every minute, and the percentage of changes of absorbance at 520 nm was recorded. After sufficient Ca 2ϩ loading, an abrupt decrease in A 520 absorbance seems to be the result of MPTP opening. The amount of Ca 2ϩ needed to trigger this change is an indicator of the susceptibility of MPTP to Ca 2ϩ overload.
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Statistics
Data are expressed as mean Ϯ standard error of the mean, and group comparisons were made with Fisher's least significant difference analysis of variance. A Tukey test was used for multiple post hoc comparisons.
Results
Hemodynamic Analysis
Hemodynamics (blood pressure, heart rate, central venous pressure), blood gas, hemoglobin, and venous oxygen saturations were monitored. At baseline, there were no differences between groups. During reperfusion, heart rate in the CCP group was increased at 1, 3, and 6 hours of reperfusion compared with the non-CPB group. Pretreatment with CsA prevented the heart rate increase. Arterial pH and base excess in the CCP group at 1 hour of reperfusion was decreased compared with the non-CPB group (7.30 Ϯ 0.04 and Ϫ3.9 Ϯ 1.3 vs 7.42 Ϯ 0.02 and 0.9 Ϯ 0.5, respectively; P Ͻ .05). There were no differences in the value of pH and base excess between the non-CPB group and CCP ϩ CsA groups. Hemodynamic data are included in Table E1 .
Electron Microscopy
Representative electron microscopic images are shown in Figure 1 . In contrast with the normal appearance of the mitochondrial cristae in the non-CPB mitochondria, there is extensive disarrangement in cristal architecture with narrowing of the mitochondrial intermembrane space in the CCP mitochondria. Despite the pronounced alterations in cristal architecture, the outer mitochondrial membranes ap-pear to be intact. In contrast, the mitochondrial cristal architecture was well preserved in the CCP ϩ CsA group.
Mitochondrial Bax Translocation
Mitochondrial Bax content was greater in CCP myocardium when compared with that in the non-CPB and CCP ϩ CsA myocardium (0.78 Ϯ 0.08 AU vs 0.47 Ϯ 0.06 AU and 0.57 Ϯ 0.06 AU, P Ͻ .01), which is consistent with translocation of Bax from the cytosol to the mitochondria (Figure 2 ).
Mitochondrial Permeabilization and Cytochrome c Release
Cytosolic cytochrome c concentrations were higher in CCP compared with non-CPB and CCP ϩ CsA myocardium (10.49 Ϯ 0.56 AU vs 7.16 Ϯ 0.61 AU and 7.33 Ϯ 0.4 AU, respectively, P Ͻ .05; Figure 2 ). Citrate synthase activity was not different between groups (0.
, and 0.09 Ϯ 0.1 mol Ϫ1 /mg Ϫ1 protein for non-CPB, CCP, and CCP ϩ CsA, respectively). Fluorescent immunohistochemistry was used to compare the patterns of cytochrome c and COX IV staining (Figure 3, A) . Release of cytochrome c from the mitochondria causes diffusion of the cytochrome c staining in the cytoplasm, and a stippled green pattern is produced. This pattern is prominent in the merged images from the CCP myocardium, whereas in non-CPB and CCP ϩ CSA myocardium, only faint diffusion of cytochrome c staining in the merged images was found. The contribution of the green color intensity to the colocalization of these color voxels in the merged images was quantified by overlap coefficients (Kxgreen) (Figure 3. B) . Compared with non-CPB and CCP ϩ CsA myocardium, lower overlap coefficient (Kx-green) was found in CCP myocardium (P Ͻ .01). 
CSP
Clark Electrode Oxygen Consumption Measurements
Isolated mitochondrial oxygen consumption was assessed during state 2 respiration for mitochondrial Complexes I, II, and IV and was not different between groups, suggesting comparable levels of mitochondrial integrity after fractionation. Cardioplegic arrest was associated with diminished state 3 respiration at Complex I. The decrement in the ratio of state 3 to state 2 respiration was prevented by pretreatment with CsA (22.4 Ϯ 2.0, 11.8 Ϯ 2.0, and 25.9 Ϯ 1.9 for non-CPB, CCP, and CCP ϩ CsA, respectively, P Ͻ .01) ( Table 1) . Complex II and Complex IV oxygen consumption rates were not different.
TUNEL Staining
TUNEL-positive nuclei were more frequent in CCP myocardium when compared with those in non-CPB and CsA groups (1.7% Ϯ 0.2% vs 0.1% Ϯ 0.037% and 0.6% Ϯ 0.1%, respectively; P Ͻ .01 and P Ͻ .05). There was no statistical difference in TUNEL-positive myocytes between the non-CPB and CCP ϩ CsA groups (Figure 4 ).
Mitochondrial Calcium Tolerance
The amount of Ca 2ϩ required to trigger MPTP opening of mitochondria was similar when comparing non-CPB and CCP mitochondria, suggesting that calcium overload is not a significant contributor to mitochondrial dysfunction 6 hours after cardioplegic arrest. CCP ϩ CsA mitochondria were resistant to calcium-induced mitochondrial swelling, suggesting that CsA inhibited MPTP opening to a "supranormal" level (eg, beyond the resistance associated with non-CPB mitochondria). The calcium required to trigger MPTP opening was 136.6 Ϯ 4.74 mol/L/mg vs 84.8 Ϯ 6.48 mol/L/mg and 93.4 Ϯ 5.15 mol/L/mg protein for CCP ϩ CsA, CCP, and non-CPB, respectively (P Ͻ .05).
Discussion
In the current study, postcardioplegic myocardium is associated with Bax translocation to the mitochondria, mitochondrial permeabilization, disarrangement of mitochondrial structure, release of cytochrome c into the cytoplasm, and a deficit of mitochondrial Complex I activity. Pretreatment with CsA, an MPTP opening inhibitor, prevents these changes, suggesting that prevention of MPTP opening may mitigate the mitochondrial effects of cardioplegic arrest.
The importance of these findings rests in the role of mitochondria as crucial cellular organelles controlling cell fate, ion homeostasis, and energy production. During the reperfusion period, mitochondrial structural and functional remodeling is associated with transmission of death signals (eg, cytochrome c) to apoptosis executioner proteins. 5 The linkage between death stimuli and subsequent apoptosis is provided by multiple signaling pathways converging on the mitochondria, including Bcl-2 family proteins. 20 Among the Bcl-2 family of proteins, Bax is a known intermediate that can initiate permeabilization of mitochondria 21 through direct pore-forming activity on the mitochondrial outer membrane and is associated with inhibition of mitochondrial respiratory chain activity. 22, 23 The translocation of Bax in the current study is consistent with a role for Bax in the mitochondrial release of cytochrome c after cardioplegic arrest.
In addition to triggering a postmitochondrial apoptotic cascade, cytochrome c is an important component of mitochondrial oxidative phosphorylation. A relative deficiency of mitochondrial cytochrome c has been reported to be responsible for deficits in mitochondrial respiratory chain activity and may thereby contribute to deficits in myocardial performance. 24 Therefore, a rationale is provided for a myopreservation strategy focused on maintenance of mitochondrial structural and functional integrity. 14, 25 The MPTP is an important mediator of mitochondrial integrity, 26 and inhibition of MPTP opening is associated with improved recovery of cardiac function after ischemic injury. 27 Consequently, direct inhibition of MPTP opening with CsA may provide a valuable target for cardioprotection against ischemia/reperfusion injury.
In addition to MPTP inhibition, CsA also inhibits calcineurin, which may alter intracellular calcium homeostasis after ischemia/reperfusion injury. It is important to rule out indirect protection of the mitochondria through alterations in calcium handling. Calcineurin-mediated alterations in postreperfusion calcium loading are unlikely to be responsible for the findings of the present study for 2 reasons. First, Nathan and colleagues, 15 using FK506 (a specific calcineurin inhibitor) in a similar in vitro cardioplegia model, demonstrated that the myopreservation effect of CsA is independent of calcineurin. In addition, in the present study, the calcium tolerance of mitochondrial MPTP opening was assessed using incremental administration of extramitochondrial calcium. The nearly identical tolerance of the CCP and non-CPB mitochondria suggests that postcardioplegia alterations in mitochondrial structure and function are not the result of calcineurin-mediated alterations in calcium loading of the mitochondria at 6 hours of reperfusion. The greater calcium tolerance of the CsA-treated mitochondria suggests that CsA inhibits MPTP opening after cardioplegic arrest. It is possible, however, that elevated cytosolic calcium concentrations earlier in the postoperative period (eg, Ͻ6 hours of reperfusion) may have played an important role in the observed alterations in mitochondrial structure and function.
The precise mechanism whereby cytochrome c is released across the outer mitochondrial membrane in the current study is not certain. MPTP opening has been described as occurring in 1 of 2 modes: transient and longlasting, the latter is often irreversible. 9 Because the surface area of the inner mitochondrial membrane exceeds that of the outer membrane, extensive matrix swelling with longlasting MPTP opening can lead to the unfolding of cristae within the inner mitochondrial membrane, causing the outer membrane to rupture with irreversible release of cytochrome c. 27 This mechanism does not appear to be present in the current study because the electron microscopy data demonstrated mitochondria in the CCP group that are highly remodeled in terms of cristal architecture but with little evidence of mitochondrial swelling or rupture of the outer mitochondrial membranes. In addition, citrate synthase activity was not increased in the CCP groups, suggesting that the structural integrity of the outer mitochondrial membrane was maintained in the CCP mitochondria. Therefore, if MPTP opening is the mechanism of cytochrome c release in the current study, a transient opening is more likely to be present than a long-lasting or permanent opening.
Another possible mechanism of cytochrome c release in the current study is direct Bax-mediated mitochondrial membrane permeabilization. 28 Bax can directly interact with MPTP to regulate cytochrome c release 29, 30 without any apparent loss of mitochondrial membrane potential. 31 In the current study, Bax translocation to the mitochondrial fraction was inhibited by CsA. Because transient MPTP opening has been demonstrated to contribute a feedforward signal to amplify Bax translocation to the mitochondria, 32 the current data are consistent with CsA-mediated inhibition of this amplification step. Therefore, at least 2 possible mechanisms for cytochrome c release are consistent with the presented data: MPTP opening (and cytochrome c release) may be independent of Bax participation or MPTP opening may promote Bax translocation with subsequent Bax-mediated feedforward augmentation of mitochondrial permeabilization.
Conclusions
The current data suggest that MPTP-mediated alterations in mitochondrial structure and function are present after cardioplegic arrest and that inhibition of MPTP opening with CsA can ameliorate these changes. The "action" is focused at the level of the mitochondria, where postreperfusion cell survival, apoptosis, and necrosis signals are adjudicated, cell fate is determined, and energy for myocyte performance is generated. Better understanding of the cardinal role of mitochondria at the convergence point of these vital pathways will enhance myopreservation strategies for the cardiac surgeon.
